Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Collaborative Research Center at Stanford aims to produce blood-based diagnostic technology for ME / CFS

Happy #OMFScienceWednesday! Today, we talk about why the Collaborative Research Center at Stanford we are funding aims to produce blood-based diagnostic technology for ME / CFS. Here are three major reasons:

1) Cheaper and faster: Anyone familiar with ME / CFS knows how difficult, time-consuming, and expensive it is for patients to get a diagnosis. A big part of that is because standard diagnosis is quite subjective (symptom-based) rather than biological. Because blood circulates throughout our body, its contents are altered by our health state. Blood is the least invasive way to get a glimpse at our individual biological differences, which is why it is used for the diagnosis of so many diseases. Several technologies developed by Dr. Ron Davis’ team at Stanford University are able to perform procedures to characterize patient blood samples cheaply and quickly. Here’s an example: https://med.stanford.edu/…/scientists-develop-lab-on-a-chip…

2) Allows monitoring: Just as diabetics use a home fingerstick kit to monitor their glucose levels over time, a blood diagnostic would eventually allow ME / CFS patients to monitor the state of their disease, including their response to treatments, dietary changes, or stressors.

3) Points to new drugs: A test that can tell healthy blood from ME / CFS blood can also be used to identify drugs that can make ME / CFS blood behave more like healthy blood. The Collaborative Research Center at Stanford is adapting technologies to screen large collections of drugs on patient blood, which may lead to new drugs that have the potential to be effective in patients.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669